From: Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats
Treatment
RDS
Placebo
2.94 ± 0.15
Everolimus
3.25 ± 0.39
Placebo + [177Lu]Lu-DOTA-TATE
3.19 ± 0.32
Everolimus + [177Lu]Lu-DOTA-TATE
3.31 ± 0.39